Bridgewater Advisors Inc. bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 9,516 shares of the company's stock, valued at approximately $2,152,000.
Other large investors have also added to or reduced their stakes in the company. Investors Research Corp purchased a new stake in shares of Cardinal Health during the 2nd quarter worth approximately $29,000. University of Texas Texas AM Investment Management Co. purchased a new position in shares of Cardinal Health in the fourth quarter valued at $26,000. Allied Private Wealth LLC bought a new stake in Cardinal Health in the second quarter worth $30,000. Bank of Jackson Hole Trust purchased a new stake in Cardinal Health during the fourth quarter valued at $27,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in Cardinal Health during the first quarter valued at $29,000. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Trading Up 1.6%
Shares of CAH opened at $234.92 on Friday. The firm has a fifty day moving average price of $230.30 and a 200-day moving average price of $217.14. The firm has a market capitalization of $54.64 billion, a P/E ratio of 32.49, a P/E/G ratio of 1.39 and a beta of 0.49. Cardinal Health, Inc. has a 12-month low of $145.87 and a 12-month high of $258.30.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Analysts predict that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.
Analyst Ratings Changes
Several brokerages have recently issued reports on CAH. UBS Group upped their target price on shares of Cardinal Health from $274.00 to $280.00 and gave the company a "buy" rating in a research report on Wednesday. Bank of America lifted their price target on Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a research report on Thursday, July 2nd. Robert W. Baird boosted their price objective on Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a research note on Wednesday. Morgan Stanley raised their price objective on Cardinal Health from $255.00 to $265.00 and gave the company an "overweight" rating in a research note on Wednesday. Finally, Weiss Ratings raised Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Wednesday, August 5th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $265.93.
Read Our Latest Analysis on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
